59
Views
15
CrossRef citations to date
0
Altmetric
Original

Endothelial Dysfunction in Patients with Noncomplicated and Complicated Hypertension

, , , &
Pages 20-30 | Received 18 Apr 2008, Accepted 13 May 2008, Published online: 03 Jul 2009

References

  • Watson T, Goon PK, Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal 2008; 10: 1079–1088
  • Okoński P, Szram S, Banach M, Mussur M, Zaslonka J. The influence of L-arginine on secretion of nitric oxide and haemodynamic function of isolated rat's heart subjected to cold cardioplegic ischemia and reperfusion. Przegl Lek 2004; 61: 789–793
  • Ganz P, Davies PF, Leopold JA, Gimbrone MA, Aleksander RW. Short-and long-term interactions of endothelium on vascular smooth muscle in coculture: Effect on cyclic GMP production. Proc Natl Acad Sci USA 1986; 83: 3552–3556
  • Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol 2003; 8: 533–541
  • Tsukahara H, Ende H, Magazine HI, Bahou WF, Goligorsky MS. Molecular and functional characterization of the non-isopeptide-selective ETb receptor in endothelial cells: Receptor coupling to nitric oxide synthase. J Biol Chem 1994; 269: 21778–21785
  • Traub O, Berk BC. Laminar shear stress. Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998; 18: 677–685
  • Malek AM, Alper SL, Izumo S. Hemodynamics shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035–2042
  • Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74: 349–353
  • Wootton DM, Ku DN. Fluid mechanics of vascular system diseases and thrombosis. Ann Rev Biomech Eng 1999; 1: 299–329
  • Busse R, Fleming I. Pulsatile stretch and shear stress: Physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998; 35: 73–84
  • Miles AM, Wink DA, Cook JG, Grisham MB. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol 1996; 268: 105–120
  • Irzmanski R, Barylski M, Banach M, Piechota M, Kowalski J, Cierniewski C, Pawlicki L. The concentration of atrial and brain natriuretic peptide in patients with idiopathic arterial hypertension. Med Sci Monit 2007; 13: CR449–456
  • Chen HI, Hu CT. Endogenous nitric oxide on arterial hemodynamics: A comparison between normotensive and hypertensive rats. Am J Physiol 1997; 273: H1816–H1824
  • Yamazaki J, Fujita N, Nagao T. NG-monomethyl-L-arginine induced pressor response at development and established stages in spontaneously hypertensive rats. J Pharmacol Exp Ther 1991; 259: 52–57
  • Fozard JR, Part ML. Haemodynamic responses to NG – monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 1991; 102: 823–826
  • Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995; 91: 2310–2313
  • Bouloumié A, Bauersachs J, Linz W, Schölkens BA, Wiemer G, Fleming I, Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 1997; 30: 934–941
  • Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, Németh I. Oxidative stress in juvenile essential hypertension. J Hypertens 2003; 21: 145–152
  • Panza JA, Casino PR, Kilcoyne CH, Quyyumi AA. Role of endothelium-derived nitric oxide on the abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Circulation 1993; 87: 1468–1474
  • O'Coonnor DT, Tyrell EA, Kailasam MT, Miller LM, Martinez JA, Henry RR. Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: Mechanisms and consequences. Hypertension 2001; 37: 898–906
  • Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Lerman NC. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol 2003; 23: 885–891
  • Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, Tácito LH, Moreno H, Jr. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 2004; 12: 823–830
  • Boncler M, Gresner P, Nocun M, Rywaniak J, Dolnik M, Rysz J, Wilk R, Czyz M, Markuszewski L, Banach M, Watala C. Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation. Biochim Biophys Acta 2007; 1770: 1651–1659
  • Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 9: 1314–1319
  • Nigam A, Mitchell GF, Lambert J, Tardif JC. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 2003; 92: 395–399
  • Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness. From physiology to pharmacology. Hypertension 2004; 44: 112–116
  • Meaume S, Benetos A, Henry OF, Rudnicki A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects > 70 years of age. Arterioscler Tromb Vasc Biol 2001; 21: 2046–2050
  • Ceravolo R, Maio R, Pujia A, Sciagua A, Ventura G, Costa MC, Sesti G, Perticone F. Pulse pressure and endothelial dysfunction in never treated hypertensive patients. J Am Coll Cardiol 2003; 41: 1753–1758
  • Barylski M, Kowalczyk E, Banach M, Ciecwierz J, Pawlicki L, Kowalski J. Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology, in press
  • Bragulat E, de la Sierra A, Antonio MT, Jemenez W, Urbano-Marquez A, Coca A. Effect of salt intake on endothelium-derived factors in a group of patients with essentials hypertension. Clin Sci (Lond) 2001; 101: 73–78
  • Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci H. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80: 829–835
  • Piechota M, Banach M, Jacoń A, Rysz J. Natriuretic peptides and endothelins in cardiovascular diseases. Cell Mol Biol Lett 2008; 13: 155–181
  • Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995; 44: 431–436
  • Irzmański R, Banach M, Piechota M, Kowalski J, Barylski M, Cierniewski CZ, Pawlicki L. Atrial, brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension. The dependence on the selected morphological parameters. Clin Exp Hypertens 2007; 29(3)149–164
  • Schiffrin EL. State of the art lecture. Role endothelin-1 in hypertension. Hypertension 1999; 34: 876–881
  • Kohno M, Yasunari K, Murakowa K. Plasma immunoreactive endothelin in essentials hypertension. Am J Med 1990; 88: 614–618
  • Miyauchi T, Yanagisava M, Lida K. Age-and sex-related variation of plasma enodethelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992; 123: 1092–1093
  • Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnet JC, Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997–1001
  • Kato Y, Kijima Y, Kitakaze M, Minamino T, Matsu-Ura Y, Hashimura K, Yasuda T, Ueda T, Mori I, Hori M. Role of systemic nitric oxide metabolism for human coronary circulation. Cardiovasc Drugs Ther 2004; 18: 189–195
  • Anderson TJ, Uchata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll 1995; 26: 1235–1241
  • Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995; 91: 2310–2313
  • Fukuchi M, Giaid A. Endothelial expression of endothelial nitric oxide synthase and endothelin 1 in human coronary artery disease. Specific reference to underlying lesion. Lab Invest 1999; 79: 659–670
  • Piechota M, Banach M, Irzmanski R, Barylski M, Piechota-Urbanska M, Kowalski J, Pawlicki L. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007; 22: 232–239
  • Salomone OA, Elliot PM, Calvino R, Holt D, Kaski JC. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. Am J Coll Cardiol 1996; 28: 14–19
  • Pekdemir H, Cicek D, Camsari A, Akkus MN, Cin VG, Doven O, Parmaksiz HT, Katircibasi MT, Ozcan IT. The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow. Am. Noninvasive Electrocardiol 2004; 9: 24–33
  • Pekdemir H, Polat G, Cin VG, Camsari A, Cicek D, Akkus MN, Doven O, Katircibasi MT, Muslu M. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow. Int J Cardiol 2004; 97: 35–41
  • Camsarl A, Pekdemir H, Cicek D, Polat G, Akkus MN, Doven O, Cin VG, Katircibasi T, Parmaksiz T. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Cir J 2003; 67: 1022–1028
  • Fujiwara N, Osnai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension. Modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101: 856–861
  • Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R, Galluccio E, Pozza G, Chierchia S, Margonato A. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: Correlation with asymmetric dimethylarginine levels. Circulation 2003; 107: 429–436
  • Zoccali C, Bode-Borger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Catalliotti A, Bellanuova I, Fermo I, Frölich J, Bö ger R. Plasma concentrations of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113–2117

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.